Sunshine Biopharma

Sunshine Biopharma is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, Sunshine is engaged in the development and commercialization of science-based nutritional supplements.

LATEST NEWS

SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY  OF GEORGIA FOR COVID-19 COMPOUNDS

SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF GEORGIA FOR COVID-19 COMPOUNDS

adminFebruary 4, 20215 min read

For Immediate Release February 4, 2021 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of oncology and…

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT  APPLICATION EXTENDING PROTECTION OF Adva-27a IN CANADA UNTIL 2033

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT APPLICATION EXTENDING PROTECTION OF Adva-27a IN CANADA UNTIL 2033

adminFebruary 2, 20215 min read

For Immediate Release February 2, 2021 Montreal, Canada – (ACCESSWIRE) – Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a  pharmaceutical company focused on the research, development and commercialization of oncology and…

SUNSHINE BIOPHARMA COMPLETES APPLICATION TO UPLIST TO OTCQB

SUNSHINE BIOPHARMA COMPLETES APPLICATION TO UPLIST TO OTCQB

adminJanuary 27, 20215 min read

For Immediate Release January 27, 2021 Montreal, Quebec, Canada — (ACCESSWIRE) — Sunshine Biopharma Inc. (OTC PINK:  “SBFM”), a pharmaceutical company focused on the research, development and  commercialization of oncology…